3287, 3192, 2962, 2868, 1633, 1590, 1577, 1446, 1281, 1259, 1147,
1051, 786 and 750; dH (500 MHz; C6D6; 65 ◦C; Me4Si) 0.79 (9H, s,
(CH3)3C), 3.74–3.88 (3H, m, CH2O + CHN), 3.81 (3H, s, CH3O-
Pyr-C6), 6.26 (1H, d, J 7.8, Pyr-C(3)H or Pyr-C(5)H), 6.44 (1H,
d, J 7.8, Pyr-C(5)H or Pyr-C(3)H), 6.79 (1H, app td, J 7.5 and 1.0,
Ph-C(4)H), 7.11 (1H, t, J 7.8, Pyr-C(4)H), 7.29 (1H, ddd, J 8.7, 7.2
and 1.6, Ph-C(5)H), 8.05 (1H, dd, J 7.8 and 1.6, Ph-C(3)H), 8.93
(1H, app d, J 8.7, Ph-C(6)H), 12.06 (1H, br s, NH); dC (125 MHz;
C6D6; 65 ◦C; Me4Si) 25.5 (3C, (CH3)3C), 33.4 ((CH3)3C), 52.8
(CH3O-Pyr-C6), 66.6 (CH2O), 76.1 (CHN), 100.8 (Pyr-C(3)H
or Pyr-C(5)H), 102.9 (Pyr-C(5)H or Pyr-C(3)H), 111.7 (Ph-C2),
117.9 (Ph-C(6)H), 118.5 (Ph-C(4)H), 129.4 (Ph-C(3)H), 131.8
(Ph-C(5)H), 139.5 (Pyr-C(4)H), 143.5 (Ph-C1), 154.1 (Pyr-C2),
163.7 (Pyr-C6), 164.0 (N=CO); m/z (ESI) 326.4 (MH+).
C(5)H), 7.43 (1H, t, J 7.9, Pyr-C(4)H), 7.84 (2H, dd, J 7.8 and
1.7, Ph-C(3)H), 8.72 (2H, app d, J 8.7, Ph-C(6)H), 11.68 (2H, br s,
NH); dC (100 MHz; CDCl3; Me4Si) 25.9 (6C, (CH3)3C), 33.9 (2C,
(CH3)3C), 67.1 (2C, CH2O), 76.3 (2C, CHN), 103.0 (Pyr-C(3)H
and Pyr-C(5)H), 111.5 (2C, Ph-C2), 118.4 (2C, Ph-C(6)H), 118.6
(2C, Ph-C(4)H), 129.3 (2C, Ph-C(3)H), 131.8 (Pyr-C(4)H), 138.5
(2C, Ph-C(5)H), 142.9 (2C, Ph-C1), 153.9 (2C, Pyr-C2), 163.7 (2C,
N=CO); m/z (ESI) 512.2 (MH+).
N2 -{2-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl}-
N6-(2-[(4S)-4-phenyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl)pyridine-
2,6-diamine 13. Ligand 13 was prepared from amine 4a (159 mg,
0.69 mmol), 6-bromopyridine 11 (217 mg, 0.58 mmol), NaOt-Bu
(66.3 mg, 0.69 mmol), Xantphos (33.6 mg, 0.058 mmol), Pd2dba3
(13.3 mg, 0.015 mmol, 5 mol% Pd) in 2.3 mL of toluene. The
mixture was heated at 165 ◦C for 1h in a microwave apparatus with
the initial power supplied being 300W. Compound 13 was obtained
as a white powder (213 mg, 69%) after purification by flash
chro◦matography on silica gel (pentane/CH2Cl2, 70/30). Mp: 138–
6-bromo-N-{2-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]-
phenyl}pyridin-2-amine 11. Ligand 11 was prepared from
amine 4e (151 mg, 0.69 mmol), 2,6-dibromopyridine (136 mg,
0.58 mmol), NaOt-Bu (66.3 mg, 0.69 mmol), Xantphos (33.6 mg,
0.058 mmol), Pd2dba3 (13.3 mg, 0.015 mmol, 5 mol% Pd) in
2.3 mL of toluene. The mixture was heated at 160 ◦C for
30 min in a microwave apparatus with an initial power supplied
being 300W. The compound 11 was obtained as a white powder
(128 mg, 59%) after purification by flash chromatography on silica
gel (pentane/CH2Cl2, 80/20). Mp: 68–71 ◦C; TLC: Rf = 0.26
20
140 C; TLC: Rf= 0.35 (pentane/CH2Cl2, 70/30); [a]D +185.1
(c 1.0 in CHCl3); found: C, 73.9; H, 6.5; N, 12.6. C33H33N5O2
requires C, 74.6; H, 6.3; N, 13.2%; umax(KBr)/cm-1 3398, 3267,
3030, 2918, 2849, 1629, 1567, 1436, 1268, 1155, 1064, 749 and
697; dH (400 MHz; CDCl3; Me4Si) 0.99 (9H, s, (CH3)3C), 4.12–
4.21 (3H, m, tBu-CHCH2O + tBu-CHN + Ph-CHCH2O), 4.26–
4.33 (1H, m, tBu-CHCH2O), 4.78 (1H, dd, J 10.0 and 8.5, Ph-
CHCH2O), 5.54 (1H, dd, J 9.0 and 8.5, Ph-CHN), 6.30 (1H, d, J
7.8, Pyr-C(5)H or Pyr-C(3)H), 6.36 (1H, d, J 7.8, Pyr-C(3)H or
Pyr-C(5)H), 6.86 (1H, app td, J 8.0 and 1.0, Ph-C(4)H), 6.91
(1H, app td, J 8.0 and 1.0, Ph-C(4)H), 7.27–7.45 (8H, m, 2 ¥
Ph-C(5)H + Pyr-C(4)H + Ph-CHN), 7.82 (1H, dd, J 7.9 and 1.6,
Ph-C(3)H), 7.91 (1H, dd, J 7.9 and 1.6, Ph-C(3)H), 8.68 (1H, app
d, J 7.8, Ph-C(6)H), 8.72 (1H, app d, J 7.8, Ph-C(6)H), 11.52 (1H,
br s, NH), 11.85 (1H, br s, NH); dC (100 MHz; CDCl3; Me4Si)
26.0 (3C, (CH3)3C), 33.9 ((CH3)3C), 67.1 (tBu-CHCH2O), 70.0
(Ph-CHN), 73.1 (Ph-CHCH2O), 76.1 (tBu-CHN), 103.2 + 103.3
(Pyr-C(3)H + (Pyr-C(5)H), 111.3 + 111.5 (2 ¥ Ph-C2), 118.3–
118.6 (4C, 2 ¥ Ph-C(6)H) + 2 ¥ (Ph-C(4)H)), 126.4 (2C, Ph-CHN),
127.5 (1C, Ph-CHN), 128.7 (2C, Ph-CHN), 129.2 + 129.5 (2 ¥ Ph-
C(3)H), 131.8 + 132.1 (2 ¥ Ph-C(5)H), 138.5 (Pyr-C(4)H), 142.3
(CIV, PhCHN), 142.9 + 143.1 (2 ¥ Ph-C1), 153.8 (2C, 2 ¥ Pyr-C2),
163.7 + 165.2 (2 ¥ N=CO); m/z (ESI) 532.4.2 (MH+).
20
(pentane/CH2Cl2, 80/20); [a]D +16.0 (c 1.0 in CHCl3); found:
C, 58.1; H, 5.4; N, 10.9. C18H20BrN3O requires C, 57.8; H, 5.4;
N, 11.2%; umax(KBr)/cm-1 3274, 3047, 2962, 2904, 1633, 1586,
1523, 1449, 1357, 1281, 1159, 1054, 777 and 752; dH (300 MHz;
CDCl3; Me4Si) 1.55 (9H, s, (CH3)3C), 4.12–4.22 (2H, m, CH2O +
CHN), 4.3 (1H, dd, J 13.1 and 11.7, CH2O), 6.66 (1H, d, J 8.1,
Pyr-C(3)H), 6.83–6.98 (2H, m, Pyr-C(5)H and Ph-C(4)H), 7.34
(1H, app t, J 7.8, Pyr-C(4)H), 7.48 (1H, app td, J 8.5 and 1.3, Ph-
C(5)H), 7.81 (1H, dd, J 7.8 and 1.3, Ph-C(3)H), 8.81 (1H, d, J 8.5,
Ph-C(6)H), 12.10 (1H, br s, NH); dC (75 MHz; CDCl3; Me4Si) 25.9
(3C, (CH3)3C), 34.1 ((CH3)3C), 67.2 (CH2O), 76.1 (CHN), 110.6
(Pyr-C(3)H), 111.6 (Ph-C2), 117.5 (Ph-C(6)H), 118.2 (Pyr-C(5)H
or Ph-C(4)H), 119.6 (Ph-C(4)H or Pyr-C(5)H), 129.3 (Ph-C(3)H),
132.4 (Ph-C(5)H), 139.0 (Pyr-C(4)H), 139.4 (Pyr-C6), 142.0 (Ph-
C1), 155.1 (Pyr-C2), 163.8 (N=CO); m/z (ESI) 374.1/376.1 in a
ratio 1/1 (MH+).
N2 -{2-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl}-
N6 -(2-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl)-
pyridine-2,6-diamine 12. Ligand 12 was prepared from amine 4e
(141 mg, 0.69 mmol), 2,6-dibromopyridine (68 mg, 0.29 mmol),
NaOt-Bu (66.3 mg, 0.69 mmol), Xantphos (16.8 mg, 0.029 mmol),
Pd2dba3 (6.6 mg, 0.007 mmol, 5 mol% Pd) in 1.1 mL of toluene.
The mixture was heated at 175 ◦C for 45 min in a microwave appa-
ratus with an initial power supplied being 300W. The compound
12 was obtained as a white powder (104 mg, 70%) after purification
by flash chromatography on silica gel (pentane/CH2Cl2, 55/45).
N2 -{2-[(4S)-4-tert-butyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl}-
N6-(2-[(4S)-4-benzyl-4,5-dihydro-1,3-oxazol-2-yl]phenyl)pyridine-
2,6-diamine 14. Ligand 14 was prepared from amine 4b (174 mg,
0.69 mmol), 6-bromopyridine 11 (217 mg, 0.58 mmol), NaOt-Bu
(66.3 mg, 0.69 mmol), Xantphos (33.6 mg, 0.058 mmol), Pd2dba3
(13.3 mg, 0.015 mmol, 5 mol% Pd) in 2.3 mL of toluene. The
mixture was heated at 165 ◦C for 1h in a microwave apparatus
with the initial power supplied being 300W. Compound 14 was
obtained as a white powder (253 mg, 80%) after purification by
flash chromatography on silica gel (pentane/CH2Cl2, 80/20). Mp:
Mp: 140–142 ◦C; TLC: Rf= 0.37 (pentane/CH2Cl2, 55/45); [a]D
20
◦
20
-3.7 (c 1.0 in CHCl3); found: C, 72.4; H, 7.2; N, 13.4. C31H37N5O2
requires C, 72.8; H, 7.3; N, 13.7%; umax(KBr)/cm-1 3428, 3100,
2958, 2919, 1634, 1567, 1434, 1357, 1283, 1255, 1154, 1054 and
749; dH (400 MHz; CDCl3; Me4Si) 1.01 (18H, s, (CH3)3C), 4.14–
4.22 (4H, m, CH2O + CHN), 4.27–4.33 (2H, m, CH2O), 6.39
(2H, d, J 7.9, Pyr-C(5)H and Pyr-C(3)H), 6.89 (2H, app td, J
7.8 and 1.1, Ph-C(4)H), 7.39 (2H, ddd, J 8.7, 7.5 and 1.7, Ph-
84–86 C; TLC: Rf= 0.47 (pentane/CH2Cl2, 80/20); [a]D -7.2
(c 1.0 in CHCl3); found: C, 74.6; H, 6.7; N, 12.6. C34H35N5O2
requires C, 74.8; H, 6.5; N, 12.8%; umax(KBr)/cm-1 3189, 3099,
2963, 2902, 1634, 1567, 1436, 1358, 1279, 1256, 1155, 1056 and
750; dH (300 MHz; CDCl3; Me4Si) 1.00 (9H, s, (CH3)3C), 2.88 (1H,
dd, J 13.6 and 7.6, PhCH2), 3.04 (1H, dd, J 13.6 and 7.6, PhCH2),
4.01–4.04 (5H, m, tBu-CHCH2O + tBu-CHN + Bn-CHCH2O),
This journal is
The Royal Society of Chemistry 2009
Org. Biomol. Chem., 2009, 7, 1723–1734 | 1731
©